Results 231 to 240 of about 20,263 (262)

Prior Authorization, Quantity Limits, and Costs for Varenicline in Medicare.

JAMA Netw Open
Jiang C, Nipp RD, Hong AS, Shih YT, Xing J, Mullins MA, Yabroff KR, Liao JM.   +7 more
europepmc   +1 more source

Text Message (SMS) Microlearning for Tobacco Use Disorder: Pre-Post Pilot Study of Clinician Confidence.

JMIR Med Educ
Dhanani Z, Dronamraju V, Garfield J.
europepmc   +1 more source

Geographic Disparities by Rural-Urban Status and Drive Time to Care in Tobacco Treatment for COPD.

JAMA Netw Open
Baldomero AK, Melzer AC, Kunisaki KM, Wendt CH, Vardeny O, Hagedorn HJ, Fu SS, Dudley RA.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Varenicline

Reactions Weekly, 2012
Mohammed Gabr, Kassem, Abdullah M, Al Hossaini   +1 more
  +11 more sources

Cytisine Versus Varenicline for Smoking Cessation in a Primary Care Setting: A Randomized Non-inferiority Trial.

Nicotine & Tobacco Research, 2023
INTRODUCTION A smoking-cessation program was implemented as a randomized non-inferiority trial in primary care practices in Croatia and Slovenia to investigate whether a standard 4-week treatment with cytisine was at least as effective and feasible as a ...
T. Oreskovic, Sanja Percac-Lima, Jeffrey M. Ashburner, H. Tiljak, J. Rifel, Zalika Klemenc Ketiš, Stjepan Oreskovic   +6 more
semanticscholar   +1 more source

Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis

Journal of addiction medicine, 2023
Objective An overview, meta-analysis, and trial sequential analysis were conducted to evaluate the efficacy and safety of varenicline for smoking cessation.
X. Shang, F. E, Kangle Guo, Chaoqun Yang, Liying Zhou, Yanan Wu, Kehu Yang, Xiuxia Li   +7 more
semanticscholar   +1 more source

Intranasal Varenicline: Review of a Novel Formulation for the Treatment of Dry Eye Disease

Journal of pharmacy and practice, 2022
Objective: To examine the literature pertaining to safety and efficacy of intranasal (IN) varenicline for the treatment of dry eye disease (DED). Data Sources: A literature search of PubMed was performed (1985 to January 2022) using the following search ...
K. Zitko, Lauren Ladd, T. Dougherty
semanticscholar   +1 more source

Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.

Alcoholism: Clinical and Experimental Research, 2022
BACKGROUND The U.S. Food and Drug Administration identifies abstinence and the absence of heavy drinking days as outcomes for pharmacotherapy trials for alcohol use disorder (AUD).
Steven J. Nieto, Craig K. Enders, K. Witkiewitz, S. O'Malley, L. Ray   +4 more
semanticscholar   +1 more source